Related Experiment Video
Updated: Mar 26, 2026
Multianimal Magnetic Resonance Imaging for Tumor Measurements in Pancreatic Cancer Mouse Models
Published on: February 3, 2026
Molecular targets for the treatment of pancreatic cancer: Clinical and experimental studies
Tasuku Matsuoka1, Masakazu Yashiro1
1Tasuku Matsuoka, Masakazu Yashiro, Department of Surgical Oncology, Osaka City University Graduate School of Medicine, Osaka 545-8585, Japan.
Abstract:
Pancreatic cancer is the fourth most common cause of cancer deaths worldwide. Although recent therapeutic developments for patients with pancreatic cancer have provided survival benefits, the outcomes for patients with pancreatic cancer remain unsatisfactory. Molecularly targeted cancer therapy has advanced in the past decade with the use of a number of pathways as candidates of therapeutic targets. This review summarizes the molecular features of this refractory disease while focusing on the recent clinical and experimental findings on pancreatic cancer. It also discusses the data supporting current standard clinical outcomes, and offers conclusions that may improve the management of pancreatic cancer in the future.
Insights
Pancreatic cancer remains a leading cause of cancer death worldwide. This review explores molecular features and therapeutic targets for pancreatic cancer, aiming to improve patient outcomes.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Pancreatic cancer is a significant global health challenge, ranking as the fourth leading cause of cancer mortality.
- Despite recent therapeutic advancements, patient outcomes for pancreatic cancer remain largely unsatisfactory.
- The field of molecularly targeted cancer therapy has seen substantial progress, identifying numerous pathways for therapeutic intervention.
Purpose of the Study:
- To review the molecular characteristics of pancreatic cancer.
- To summarize recent clinical and experimental findings related to pancreatic cancer therapies.
- To discuss data supporting current treatment standards and propose future management strategies.
Main Methods:
- Literature review of molecular features of pancreatic cancer.
- Analysis of recent clinical trial data for pancreatic cancer treatments.
- Examination of experimental findings on novel therapeutic targets.
Main Results:
- Identification of key molecular pathways implicated in pancreatic cancer.
- Evaluation of the efficacy and limitations of current pancreatic cancer treatments.
- Synthesis of data supporting existing clinical outcomes.
Conclusions:
- Understanding the molecular landscape is crucial for advancing pancreatic cancer treatment.
- Targeted therapies hold promise but require further refinement for refractory pancreatic cancer.
- Future management strategies should integrate molecular insights for improved patient survival and care.
